Ams Osram has finalized the disposal of its non‑optical analog and mixed‑signal sensor business to Infineon, pocketing €570m in cash that will be channeled straight into debt reduction. The transaction, first announced in February 2026 and cleared by all regulatory bodies, closed on 1 July. Around 230 employees from research, development and management now move to Infineon, which expects the acquired unit to contribute roughly €230m in revenue in 2026 and to be immediately accretive to its earnings per share.
Yet the market greeted the milestone with a yawn. Ams Osram’s stock slipped 3.32% on Friday to close at €20.40, leaving it with a weekly loss of 5.99% and a month‑to‑date gain of 18.26%. The deal’s completion is the centrepiece of a broader deleveraging campaign that also includes the refinancing of senior notes in May and June. Together, these steps are expected to slash annual interest expenses by around €40m. Chief Executive Aldo Kamper has set a clear medium‑term target: the company aims to generate positive free cash flow for the first time since its restructuring drive by 2027, and analysts see positive earnings per share arriving no earlier than that year.
Rating agencies remain cautious, however. Fitch calculates that Ams Osram’s EBITDA leverage at the end of 2025 was higher than the pro‑forma ratio communicated by management, suggesting the balance‑sheet cleanup still has some way to go. The €570m infusion will help, but the market appears to be pricing in a long slog rather than a quick fix.
Should investors sell immediately? Or is it worth buying Ams Osram?
The valuation picture is equally muddled. Analyst price targets diverge dramatically. Data from Fintel show a mean one‑year target of CHF 10.98, with a range spanning CHF 7.14 to CHF 15.54 — all well below current levels. Cash.ch reports a similar average of CHF 15.50. In stark contrast, a discounted cash‑flow model by Simply Wall St, cited by Yahoo Finance, pegs fair value at CHF 49.36, roughly 2.7 times the CHF 18.35 share price at the time of the analysis. Whether those cash‑flow projections are attainable for a company still posting losses and unlikely to turn profitable within three years is an open question. On a conventional price‑to‑sales basis, Ams Osram trades at 0.6x trailing revenue of €3.299bn (market cap: €2.12bn), versus the sector median of 4.8x — a gap that could signal either deep undervaluation or structural concerns.
Technically, the stock is hovering near its 50‑day moving average of €20.20, with the relative strength index at 51.6 — a neutral reading that suggests neither overbought nor oversold conditions. The 200‑day average stands at €12.39, meaning the current price is 64.63% above that level, a testament to the extraordinary rally from December’s 52‑week low of €7.38. Still, the share is 23.6% below the 52‑week high of €26.70 set on 26 May 2026, and the annualized 30‑day volatility of almost 99% underscores how violently the stock can swing.
For the weeks ahead, investors will weigh two cross‑currents: the concrete interest savings and portfolio focus from the Infineon deal, and the stubbornly wide gap between the most optimistic and most pessimistic views on the company’s intrinsic worth. The first major checkpoint remains the 2027 free‑cash‑flow milestone — a test that will ultimately separate the bullish narrative from the cautionary one.
Ad
Ams Osram Stock: Buy or Sell?! New Ams Osram Analysis from July 12 delivers the answer:
The latest Ams Osram figures speak for themselves: Urgent action needed for Ams Osram investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from July 12.
Ams Osram: Buy or sell? Read more here...










